Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)
Phase 1
- Conditions
- HER2-NegativeEstrogen Receptor-PositiveMetastatic Breast CancerLocally Advanced Breast Cancer
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- EnhancedBio USA Inc.
- Target Recruit Count
- 106
- Registration Number
- NCT04669587
- Locations
- 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States
🇰🇷National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷CHA Bundang Medical Center, CHA University, Seongnam-si, Korea, Republic of
News
No news found